173 related articles for article (PubMed ID: 27595938)
1. Effects of ligand binding on the stability of aldo-keto reductases: Implications for stabilizer or destabilizer chaperones.
Kabir A; Honda RP; Kamatari YO; Endo S; Fukuoka M; Kuwata K
Protein Sci; 2016 Dec; 25(12):2132-2141. PubMed ID: 27595938
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
3. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of an aldo-keto reductase by minimal loop engineering.
Krump C; Vogl M; Brecker L; Nidetzky B; Kratzer R
Protein Eng Des Sel; 2014 Jul; 27(7):245-8. PubMed ID: 24951537
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry.
Kabir A; Endo S; Toyooka N; Fukuoka M; Kuwata K; Kamatari YO
J Biochem; 2017 Feb; 161(2):215-222. PubMed ID: 28003428
[TBL] [Abstract][Full Text] [Related]
6. Selective Inhibition of Human AKR1B10 by
Seliger JM; Cicek SS; Witt LT; Martin HJ; Maser E; Hintzpeter J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30469331
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.
Luo D; Bu Y; Ma J; Rajput S; He Y; Cai G; Liao DF; Cao D
J Biol Chem; 2013 Dec; 288(51):36733-40. PubMed ID: 24217247
[TBL] [Abstract][Full Text] [Related]
8. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
9. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.
Ruiz FX; Moro A; Gallego O; Ardèvol A; Rovira C; Petrash JM; Parés X; Farrés J
Chem Biol Interact; 2011 May; 191(1-3):199-205. PubMed ID: 21329680
[TBL] [Abstract][Full Text] [Related]
10. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
11. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
Sotriffer CA; Krämer O; Klebe G
Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
[TBL] [Abstract][Full Text] [Related]
12. A Novel Aldo-Keto Reductase, HdRed, from the Pacific Abalone Haliotis discus hannai, Which Reduces Alginate-derived 4-Deoxy-L-erythro-5-hexoseulose Uronic Acid to 2-Keto-3-deoxy-D-gluconate.
Mochizuki S; Nishiyama R; Inoue A; Ojima T
J Biol Chem; 2015 Dec; 290(52):30962-74. PubMed ID: 26555267
[TBL] [Abstract][Full Text] [Related]
13. Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.
Liu Z; Zhong L; Krishack PA; Robbins S; Cao JX; Zhao Y; Chung S; Cao D
Gene; 2009 May; 437(1-2):39-44. PubMed ID: 19236911
[TBL] [Abstract][Full Text] [Related]
14. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
[TBL] [Abstract][Full Text] [Related]
15. Selectivity determinants of inhibitor binding to the tumour marker human aldose reductase-like protein (AKR1B10) discovered from molecular docking and database screening.
Zhao HT; Soda M; Endo S; Hara A; El-Kabbani O
Eur J Med Chem; 2010 Sep; 45(9):4354-7. PubMed ID: 20538382
[TBL] [Abstract][Full Text] [Related]
16. AKR1A1 is a novel mammalian
Stomberski CT; Anand P; Venetos NM; Hausladen A; Zhou HL; Premont RT; Stamler JS
J Biol Chem; 2019 Nov; 294(48):18285-18293. PubMed ID: 31649033
[TBL] [Abstract][Full Text] [Related]
17. The xylose reductase (AKR2B5) structure: homology and divergence from other aldo-keto reductases and opportunities for protein engineering.
Wilson DK; Kavanagh KL; Klimacek M; Nidetzky B
Chem Biol Interact; 2003 Feb; 143-144():515-21. PubMed ID: 12604237
[TBL] [Abstract][Full Text] [Related]
18. Novel Aldo-Keto Reductases for the Biocatalytic Conversion of 3-Hydroxybutanal to 1,3-Butanediol: Structural and Biochemical Studies.
Kim T; Flick R; Brunzelle J; Singer A; Evdokimova E; Brown G; Joo JC; Minasov GA; Anderson WF; Mahadevan R; Savchenko A; Yakunin AF
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28130301
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of a novel aldo-keto reductase from Aloe vera.
Jangra A; Chaturvedi S; Sihag S; Sharma G; Tiwari S; Chhokar V
Planta; 2023 Oct; 258(6):107. PubMed ID: 37897513
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]